The first commercial use of the Tack Endovascular System® has been launched in multiple hospitals within Germany.  The news was reported today by Intact Vascular, Inc., developer of medical devices for minimally invasive peripheral vascular procedures.  A novel therapy for dissection repair following balloon angioplasty, the Tack® implant is a first-of-its kind device for patients with peripheral arterial disease (PAD) and/or critical limb ischemia (CLI).

“The Tack System provides a much-needed therapeutic option for treating dissections in the superficial femoral or popliteal arteries following balloon angioplasty,” said Dr. Christian Wissgott, Assistant Director, at Westküstenklinikum Heide in Heide, Germany. “I am very pleased with my experience using the implant, and I am excited to incorporate this technology into my above and below the knee treatment algorithms going forward.”

Patients treated with balloon angioplasty frequently suffer from dissections. Often overlooked, undiagnosed and untreated, dissections can lead to acute thrombosis and arterial occlusions, which lower long-term patency rates and require repeat procedures. Designed to resolve these dissections while leaving minimal metal behind, the Tack implant is uniquely designed to preserve vessel integrity, minimize vessel inflammation and enhance blood flow.

“With the Tack System, balloon angioplasty results are improved regardless if it is drug-eluting or not,” noted Dr. Michael K.W. Lichtenberg, Chief of Angiology Clinic and Venous Center, Klinikum Arnsberg in Germany. “Based on my initial experience, I am confident this new paradigm of focal dissection repair will become standard of care for patients undergoing PAD interventions.”

“Commercializing the Tack Endovascular System is a major achievement for our company and ultimately for patients undergoing balloon angioplasty,” stated Howard Rosen, Vice President of Marketing & Business Development at Intact Vascular. “We are excited to bring this impactful technology to market and look forward to expanding our commercial efforts in Europe.”


Reference

1Bosiers M, Scheinert D, Hendricks JMH et al. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg 2016;64:109-16.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here